To test whether MBD5 and SATB2 reduced dosage model methylation regions converged, we intersected data from each analysis and calculated the hypergeometric probability of the overlap, which was highly significant ( Figure 3d ).
1
—
—
To test whether MBD5 and SATB2 reduced dosage model methylation regions converged, we intersected data from each analysis and calculated the hypergeometric probability of the overlap, which was highly significant ( Figure 3d ).